Top

Gepubliceerd in:

Open Access 01-05-2013 | Editor's comment

Crown years for non-invasive cardiovascular imaging (Part II): 40 years of nuclear cardiology

Auteur: E. E. van der Wall

Gepubliceerd in: Netherlands Heart Journal | Uitgave 5/2013

Excerpt

The year 2013 is a remarkable year in cardiovascular medicine from a historical point of view. It can be considered a crown year for non-invasive clinical cardiovascular imaging as we can look back on 60 years of echocardiography, 40 years of nuclear cardiology, 30 years of cardiovascular magnetic resonance imaging, and 30 years of cardiac computed tomography. In a previous Editor’s Comment 60 years of echocardiography were described (Part I). In this Editor’s Comment (Part II) we will briefly look back to the roots of nuclear cardiology and its main achievements. …

volgende artikel Approaches for non-invasive assessment of endothelial function: focus on peripheral arterial tonometry

Zaret BL, Strauss HW, Martin ND, et al. Noninvasive regional myocardial perfusion with radioactive potassium. Study of patients at rest, with exercise and during angina pectoris. N Engl J Med. 1973;288:809–12.PubMedCrossRef

Wackers FJT, van der Schoot JB, Sokole EB, et al. Noninvasive visualization of acute myocardial infarction in man with thallium-201. Br Heart J. 1975;37:741–4.PubMedCrossRef

Pohost GM, Zir LM, Moore RH, et al. Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201. Circulation. 1977;55:294–302.PubMedCrossRef

Dymond DS, Stone DL, Elliott AT, et al. Cardiac emission tomography in patients using 201thallium. A new technique for perfusion scintigraphy. Clin Cardiol. 1979;2:192–6.PubMed

Pfisterer ME, Williams RJ, Gordon DG, et al. Comparison of rest/exercise ECG, thallium-201 scans and radionuclide angiography in patients with suspected coronary artery disease. Cardiology. 1980;66:43–55.PubMedCrossRef

Schelbert HR, Phelps ME, Hoffman EJ, et al. Regional myocardial perfusion assessed with N-13 labeled ammonia and positron emission computerized axial tomography. Am J Cardiol. 1979;43:209–18.PubMedCrossRef

van der Wall EE, den Hollander W, Heidendal GA, et al. Dynamic myocardial scintigraphy with 123I-labeled free fatty acids in patients with myocardial infarction. Eur J Nucl Med. 1981;6:383–9.PubMed

van der Wall EE, Heidendal GA, den Hollander W, et al. Metabolic myocardial imaging with 123I-labeled heptadecanoic acid in patients with angina pectoris. Eur J Nucl Med. 1981;6:391–6.PubMed

Kudoh T, Tamaki N, Magata Y, et al. Metabolism substrate with negative myocardial uptake of iodine-123-BMIPP. J Nucl Med. 1997;38:548–53.PubMed

10.

Parodi O, Marcassa C, Casucci R, et al. Accuracy and safety of technetium-99m hexakis 2-methoxy-2-isobutyl isonitrile (Sestamibi) myocardial scintigraphy with high dose dipyridamole test in patients with effort angina pectoris: a multicenter study. Italian Group of Nuclear Cardiology. J Am Coll Cardiol. 1991;18:1439–44.PubMedCrossRef

11.

Kapur A, Latus KA, Davies G, et al. A comparison of three radionuclide myocardial perfusion tracers in clinical practice: the ROBUST study. Eur J Nucl Med Mol Imaging. 2002;29:1608–16.PubMedCrossRef

12.

Hutchins GD, Schwaiger M, Rosenspire KC, et al. Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol. 1990;15:1032–42.PubMedCrossRef

13.

Underwood SR, Bax JJ, vom Dahl J, et al. Imaging techniques for the assessment of myocardial hibernation. Report of a Study Group of the European Society of Cardiology. Eur Heart J. 2004;25:815–36.PubMedCrossRef

14.

Boogers MJ, Borleffs CJ, Henneman MM, et al. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J Am Coll Cardiol. 2010;55:2769–77. doi:10.1016/j.jacc.2009.12.066.PubMedCrossRef

15.

Flotats A, Bravo PE, Fukushima K, et al. ⁸²Rb PET myocardial perfusion imaging is superior to ⁹⁹mTc-labelled agent SPECT in patients with known or suspected coronary artery disease. Eur J Nucl Med Mol Imaging. 2012;39:1233–9. doi:10.1007/s00259-012-2140-x.PubMedCrossRef

16.

van Eck-Smit BL, van der Wall EE, Kuijper AF, et al. Immediate thallium-201 reinjection following stress imaging: a time-saving approach for detection of myocardial viability. J Nucl Med. 1993;34:737–43.PubMed

17.

Sochor H, Pachinger O, Ogris E, et al. Radionuclide imaging after coronary vasodilation: myocardial scintigraphy with thallium-201 and radionuclide angiography after administration of dipyridamole. Eur Heart J. 1984;5:500–9.PubMed

18.

Leppo JA, O’Brien J, Rothendler JA, et al. Dipyridamole-thallium-201 scintigraphy in the prediction of future cardiac events after acute myocardial infarction. N Engl J Med. 1984;310:1014–8.PubMedCrossRef

19.

Bourguignon MH, Sokole EB, Jones B, et al. Protocols for selection of cardiac radionuclide studies for use as a data base of normal studies and typical patterns of diseases. COST B2 Working Group II, in association with relevant working/task groups of the European Association of Nuclear Medicine and the European Society of Cardiology. Eur J Nucl Med. 1993;20:59–65.PubMedCrossRef

20.

Matheijssen NA, Louwerenburg HW, van Rugge FP, et al. Comparison of ultrafast dipyridamole magnetic resonance imaging with dipyridamole SestaMIBI SPECT for detection of perfusion abnormalities in patients with one-vessel coronary artery disease: assessment by quantitative model fitting. Magn Reson Med. 1996;35:221–8.PubMedCrossRef

21.

Schroeder-Tanka JM, Tiel-van Buul MM, van der Wall EE, et al. Should imaging at stress always be followed by imaging at rest in Tc-99m MIBI SPECT? A proposal for a selective referral and imaging strategy. Int J Card Imaging. 1997;13:323–9.PubMedCrossRef

22.

Groutars RG, Verzijlbergen JF, Muller AJ, et al. Prognostic value and quality of life in patients with normal rest thallium-201/stress technetium 99m-tetrofosmin dual-isotope myocardial SPECT. J Nucl Cardiol. 2000;7:333–41.PubMedCrossRef

23.

Chua T, Kiat H, Germano G, et al. Gated technetium-99m sestamibi for simultaneous assessment of stress myocardial perfusion, postexercise regional ventricular function and myocardial viability. Correlation with echocardiography and rest thallium-201 scintigraphy. J Am Coll Cardiol. 1994;23:1107–14.PubMedCrossRef

24.

Slomka PJ, Patton JA, Berman DS, et al. Advances in technical aspects of myocardial perfusion SPECT imaging. J Nucl Cardiol. 2009;16:255–76. doi:10.1007/s12350-009-9052-6.PubMedCrossRef

25.

de Mulder M, van der Zant FM, Knaapen P, et al. Long-term clinical outcome and MIBI SPECT parameters in percutaneous coronary interventions. Neth Heart J. 2011;19:68–72.PubMedCrossRef

26.

Ten Cate TJ, Kelder JC, Plokker HW, et al. Patients with left bundle branch block pattern and high cardiac risk myocardial SPECT: does the current management suffice? Neth Heart J. 2013;21:218–24. doi:10.1007/s12471-011-0174-5.

27.

Henneman MM, Chen J, Dibbets-Schneider P, et al. Can LV dyssynchrony as assessed with phase analysis on gated myocardial perfusion SPECT predict response to CRT? J Nucl Med. 2007;48:1104–11.PubMedCrossRef

28.

Shaw LJ, Hage FG, Berman DS, et al. Prognosis in the era of comparative effectiveness research: where is nuclear cardiology now and where should it be? J Nucl Cardiol. 2012;19:1026–43. doi:10.1007/s12350-012-9593-y.PubMedCrossRef

29.

Underwood SR, Godman B, Salyani S, et al. Economics of myocardial perfusion imaging in Europe–the EMPIRE Study. Eur Heart J. 1999;20:157–66.PubMedCrossRef

30.

Fraser AG, Buser PT, Bax JJ, et al. The future of cardiovascular imaging and non-invasive diagnosis: a joint statement from the European Association of Echocardiography, the Working Groups on Cardiovascular Magnetic Resonance, Computers in Cardiology, and Nuclear Cardiology, of the European Society of Cardiology, the European Association of Nuclear Medicine, and the Association for European Paediatric Cardiology. Eur Heart J. 2006;27:1750–3.PubMedCrossRef

31.

van der Wall EE. Myocardial perfusion imaging in coronary artery disease: SPECT, PET or CMR? Neth Heart J. 2012;20:297–8. doi:10.1007/s12471-012-0300-z.PubMedCrossRef

32.

Schwaiger M, Bengel FM. From thallium scan to molecular imaging. Mol Imaging Biol. 2002;4:387–98.PubMedCrossRef

33.

Dilsizian V, Taillefer R. Journey in evolution of nuclear cardiology: will there be another quantum leap with the F-18-labeled myocardial perfusion tracers? JACC Cardiovasc Imaging. 2012;5:1269–84. doi:10.1016/j.jcmg.2012.10.006.PubMedCrossRef

34.

Beller GA. Fifty years of progress in radionuclide assessment of myocardial perfusion. J Nucl Cardiol. 2013;20:4–5. doi:10.1007/s12350-012-9666-y.PubMedCrossRef

35.

Bavelaar-Croon CD, Slart RH, Bax JJ, van der Wall EE. Cardiovascular nuclear medicine 1976/'06; 30 years representation in clinical cardiology. Ned Tijdschr Geneeskd. 2006;150:1373–9.

Titel: Crown years for non-invasive cardiovascular imaging (Part II): 40 years of nuclear cardiology
Auteur: E. E. van der Wall
Publicatiedatum: 01-05-2013
Uitgeverij: Bohn Stafleu van Loghum
Gepubliceerd in: Netherlands Heart Journal / Uitgave 5/2013
Print ISSN: 1568-5888
Elektronisch ISSN: 1876-6250
DOI: https://doi.org/10.1007/s12471-013-0392-0

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Excerpt

Log in om toegang te krijgen

Andere artikelen Uitgave 5/2013

An atypical arrhythmia

Microcirculatory function and left ventricular recovery after STEMI, exploring the hidden territories

Microsphere embolisation as an alternative for alcohol in percutaneous transluminal septal myocardial ablation

Approaches for non-invasive assessment of endothelial function: focus on peripheral arterial tonometry

Coronary microcirculatory dysfunction is associated with left ventricular dysfunction during follow-up after STEMI

Costs and benefits of treatment of myocardial infarction